Skip to main content
. 2014 Aug 13;2014:249204. doi: 10.1155/2014/249204

Table 4.

Results of fatty acid analysis with GC.

Fatty acid Before MPL (%) After MPL (%) Relative change of respective FA P
TG-fraction
Myristic acid-C14:0 1.9 (0.5–5.6) 2.2 (0.7–23.5) +16% <0.01
Palmitic acid-C16:0 23.9 (14.7–35.7) 23.2 (14.7–36.9) −3% <0.05
Stearic acid-C18:0 3.7 (1.5–8) 3.7 (1.9–7.2) 0% n.s.
Oleic acid-C18:1 34.1 (25.4–43.2) 32 (23.1–45.3) −6% <0.01
Linoleic acid (LA)-C18:2 27.6 (12.9–46.1) 29.6 (15.8–47.9) +7% <0.01
α-Linolenic acid (ALA)-C18:3 0.8 (0.1–9.6) 1 (0–5) +25% <0.001
Arachidonic acid (AA)∗-C20:4 4.1 (1.4–7.8) 3.6 (0.5–8.4) −12% <0.01
Eicosapentaenoic acid (EPA)-C20:5 0.6 (0.1–2.1) 1 (0.2–3.4) +67% <0.001
Docosahexaenoic acid (DHA)-C22:6 0.7 (0.2–2.1) 1 (0.1–2.1) +43% <0.001
∑ of median values 97.4 97.3

PL-fraction
Myristic acid-C14:0 0.3 (0.1–0.7) 0.4 (0.2–0.7) +33% <0.001
Palmitic acid-C16:0 25.4 (15.9–30) 24.9 (20.5–28.6) −2% <0.01
Stearic acid-C18:0 11.7 (8.4–16.3) 12.1 (8.4–15.8) +3% <0.001
Oleic acid-C18:1 10.6 (5.6–14.2) 10.7 (7.4–15.6) 0% n.s.
Linoleic acid (LA)-C18:2 17.4 (11.2–24.3) 18.5 (8.3–23.9) +6% <0.01
α-linolenic acid (ALA)-C18:3 0.2 (0–3.4) 0.3 (0–0.9) +50% <0.001
Arachidonic acid (AA)∗-C20:4 9.3 (3.2–14.8) 8.5 (4.3–14.4) −9% <0.001
Eicosapentaenoic acid (EPA)-C20:5 0.8 (0.2–3.4) 1.4 (0.5–4.1) +75% <0.001
Docosahexaenoic acid (DHA)-C22:6 3 (0.9–6.1) 3.6 (1.5–5.9) +20% <0.001
∑ sum of median values 78.7 75.4

∗Normal distribution.

Change of FAs after MPL supplementation based on the median initial values.

Median relative values of each FA before and after MPL supplementation in the study population (n = 123). Since most of the data is not normally distributed, all values are given in median (min–max). Since C:17 lysophosphatidylcholine was used as internal standard, the results of C:17 are not shown in the table. C17 stays mostly in the PL fraction; therefore the values of the shown FAs (% of each FA) are not based on a 100%.